During the past decade, UCLA Semel Institute - Neuropsychiatric Institute (NPI) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" #1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" are "Depression" (2 trials), "Major Depressive Disorder" (1 trials) and "Mild Cognitive Impairment (MCI)" (1 trials). Many other conditions were trialed in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" in a lesser frequency.

Most popular intervention types in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Citalopram" (1 trials), "Escitalopram" (1 trials), "Memantine" (1 trials) and "Methylphenidate (MPH)" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UCLA Semel Institute - Neuropsychiatric Institute (NPI)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in UCLA Semel Institute - Neuropsychiatric Institute (NPI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCLA Semel Institute - Neuropsychiatric Institute (NPI), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".